Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta-analysis of non-Asian studies

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHome, Philip
dc.contributor.authorLauand, Felipe
dc.contributor.authorDjaballah, Khier
dc.contributor.authorLi, Xuan\\-Tony
dc.contributor.authorHafidh, Khadija
dc.contributor.authorMehta, Roopa
dc.contributor.authorFaraoun, Khadra
dc.contributor.authorAnaforoglu, Inan
dc.contributor.authorSerafini, Paul
dc.contributor.authorPourrahmat, Mir\\-Masoud
dc.date.accessioned2025-10-16T15:11:52Z
dc.date.issued2025
dc.identifier.doi10.1111/dom.16360
dc.identifier.otherWOS:001458106200001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5083
dc.publisherWILEY
dc.sourceDIABETES OBESITY \& METABOLISM
dc.subjectfixed\\-ratio combination
dc.subjectiGlarLixi
dc.subjectinsulin therapy
dc.subjectnetwork meta\\-analysis
dc.subjecttype 2 diabetes
dc.titleEfficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta-analysis of non-Asian studies
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS